---
title: "Leascend: Net loss of 50.1619 million yuan in the first half of 2025"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254604419.md"
description: "Leascend announced that its operating revenue in the first half of 2025 is expected to be 209 million yuan, a year-on-year increase of 35.90%. The net loss attributable to shareholders of the listed company is 50.1619 million yuan, compared to a loss of 42.4225 million yuan in the same period last year. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital through reserves"
datetime: "2025-08-26T10:47:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254604419.md)
  - [en](https://longbridge.com/en/news/254604419.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254604419.md)
generator: "portal-rs"
---

# Leascend: Net loss of 50.1619 million yuan in the first half of 2025

Leascend announced that its operating revenue in the first half of 2025 was 209 million yuan, a year-on-year increase of 35.90%. The net loss attributable to shareholders of the listed company was 50.1619 million yuan, compared to a loss of 42.4225 million yuan in the same period last year. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into share capital

### Related Stocks

- [300051.CN](https://longbridge.com/en/quote/300051.CN.md)

## Related News & Research

- [Hermes eyes doubling revenue on thermal modules](https://longbridge.com/en/news/296937799.md)
- [Heybike launches low cost 28 MPH full-suspension moped-style e-bike](https://longbridge.com/en/news/296783955.md)
- [Icelandic Salmon posts H1 2026 financial report](https://longbridge.com/en/news/296863293.md)
- [AcuCort says Zeqmelit oral film wins 69% patient preference in real-world study](https://longbridge.com/en/news/296994929.md)
- [SANJOSE wins contract to build luxury villa in Ibiza’s Sant Joan de Labritja](https://longbridge.com/en/news/297008592.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**